Legal Representation
Attorney
Meghna Prasad
USPTO Deadlines
Next Deadline
796 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 19980407)
Due Date
April 07, 2028
Grace Period Ends
October 07, 2028
Application History
45 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 9, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 9, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Oct 9, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Oct 9, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Oct 9, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 4, 2023 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Sep 20, 2023 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Sep 20, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Sep 20, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 20, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 20, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 20, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 4, 2018 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | Loading... |
| Oct 4, 2018 | RNL2 | Q | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) | Loading... |
| Oct 4, 2018 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | Loading... |
| Oct 3, 2018 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Sep 27, 2018 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
| Apr 7, 2017 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Apr 17, 2008 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | Loading... |
| Apr 17, 2008 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | Loading... |
| Apr 3, 2008 | PLGL | A | ASSIGNED TO PARALEGAL | Loading... |
| Mar 26, 2008 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
| Mar 26, 2008 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| May 22, 2007 | CFIT | O | CASE FILE IN TICRS | Loading... |
| Oct 18, 2004 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 17, 2004 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Dec 12, 2003 | 815F | I | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | Loading... |
| Jun 25, 2003 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 2, 2003 | I | PAPER RECEIVED | Loading... | |
| Apr 7, 1998 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 12, 1998 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Feb 12, 1998 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 9, 1998 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Dec 16, 1997 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jul 11, 1997 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 17, 1997 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 25, 1997 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 10, 1996 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 18, 1996 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 26, 1996 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 23, 1996 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jan 24, 1996 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 18, 1996 | CNEA | F | EXAMINER'S AMENDMENT MAILED | Loading... |
| Dec 22, 1995 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 22, 1995 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations, namely retinoids, for the treatment of skin related diseases, disorders of the eye, cancer and precancerous conditions, cardiovascular disorders, inflammatory diseases, neuro-degenerative diseases, and disorders related to the modulation of apoptosis
First Use Anywhere:
May 9, 1997
First Use in Commerce:
May 9, 1997
Classification
International Classes
005